129 related articles for article (PubMed ID: 9439147)
1. Association between genetic polymorphisms of the cytochromes P-450 (1A1, 2D6, and 2E1) and the susceptibility to pancreatic cancer.
Lee HC; Yoon YB; Kim CY
Korean J Intern Med; 1997 Jun; 12(2):128-36. PubMed ID: 9439147
[TBL] [Abstract][Full Text] [Related]
2. [Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility].
Gu YF; Zhang ZD; Zhang SC; Zheng SH; Jia HY; Gu SX
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3064-8. PubMed ID: 18261353
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphism of cytochromes P450 1A1, 2D6 and 2E1: regulation and toxicological significance.
Rannug A; Alexandrie AK; Persson I; Ingelman-Sundberg M
J Occup Environ Med; 1995 Jan; 37(1):25-36. PubMed ID: 7620940
[TBL] [Abstract][Full Text] [Related]
4. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens.
Le Marchand L; Sivaraman L; Pierce L; Seifried A; Lum A; Wilkens LR; Lau AF
Cancer Res; 1998 Nov; 58(21):4858-63. PubMed ID: 9809991
[TBL] [Abstract][Full Text] [Related]
5. Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancer.
Suzuki S; Muroishi Y; Nakanishi I; Oda Y
J Gastroenterol; 2004; 39(3):220-30. PubMed ID: 15064998
[TBL] [Abstract][Full Text] [Related]
6. Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias.
Aydin-Sayitoglu M; Hatirnaz O; Erensoy N; Ozbek U
Am J Hematol; 2006 Mar; 81(3):162-70. PubMed ID: 16493615
[TBL] [Abstract][Full Text] [Related]
7. Study of the association between cytochromes P450 2D6 and 2E1 genotypes and the risk of drug and chemical induced idiosyncratic aplastic anaemia.
Marsh JC; Chowdry J; Parry-Jones N; Ellis SW; Muir KR; Gordon-Smith EC; Tucker GT
Br J Haematol; 1999 Feb; 104(2):266-70. PubMed ID: 10050706
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between the genetic polymorphisms of phase I and II drug-metabolizing enzymes, as well as the outcome of chemotherapy in advanced non-small cell lung cancer].
Li W; Yue W; Yang X; Zhang C; Wang Y
Zhongguo Fei Ai Za Zhi; 2011 Nov; 14(11):858-64. PubMed ID: 22104220
[TBL] [Abstract][Full Text] [Related]
9. [Cytochrome P450 1A1 and cytochrome P450 2E1 gene polymorphisms in Guangzhou Hans].
Wang J; Liu Z; Lu X; Chen B
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Aug; 17(4):259-61. PubMed ID: 10932010
[TBL] [Abstract][Full Text] [Related]
10. CYP2D6 and CYP1A1 mutations in the Turkish population.
Aydin M; Hatirnaz O; Erensoy N; Ozbek U
Cell Biochem Funct; 2005; 23(2):133-5. PubMed ID: 15648054
[TBL] [Abstract][Full Text] [Related]
11. CYP2A6, CYP1A1, and CYP2D6 polymorphisms in lung cancer patients from central south China.
Huang FM; Chen HC; Khan MA; Yang FL; Wan XX; Xu AH; Ou-yang FD; Zhang DZ
Med Oncol; 2013 Jun; 30(2):521. PubMed ID: 23471717
[TBL] [Abstract][Full Text] [Related]
12. [Genetic and phenotypic polymorphisms in carcinogen-metabolizing enzymes and cancer susceptibility].
Watanabe M
Nihon Rinsho; 1996 Aug; 54(8):2261-75. PubMed ID: 8810806
[TBL] [Abstract][Full Text] [Related]
13. CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer.
Silvestri L; Sonzogni L; De Silvestri A; Gritti C; Foti L; Zavaglia C; Leveri M; Cividini A; Mondelli MU; Civardi E; Silini EM
Int J Cancer; 2003 Apr; 104(3):310-7. PubMed ID: 12569554
[TBL] [Abstract][Full Text] [Related]
14. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.
Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K
Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphism of N-acetyltransferase-2, glutathione S-transferase-M1, and cytochromes P450IIE1 and P450IID6 in the susceptibility to head and neck cancer.
González MV; Alvarez V; Pello MF; Menéndez MJ; Suárez C; Coto E
J Clin Pathol; 1998 Apr; 51(4):294-8. PubMed ID: 9659241
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms of CYP2D6, CYP1A1 and CYP2E1 in the South-Amerindian population of Chile.
Muñoz S; Vollrath V; Vallejos MP; Miquel JF; Covarrubias C; Raddatz A; Chianale J
Pharmacogenetics; 1998 Aug; 8(4):343-51. PubMed ID: 9731721
[TBL] [Abstract][Full Text] [Related]
17. CYP 1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case-control study in China.
Song N; Tan W; Xing D; Lin D
Carcinogenesis; 2001 Jan; 22(1):11-6. PubMed ID: 11159735
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in glutathione S-transferases GSTM1, GSTT1 and GSTP1 and cytochromes P450 CYP2E1 and CYP1A1 and susceptibility to cirrhosis or pancreatitis in alcoholics.
Burim RV; Canalle R; Martinelli Ade L; Takahashi CS
Mutagenesis; 2004 Jul; 19(4):291-8. PubMed ID: 15215328
[TBL] [Abstract][Full Text] [Related]
19. Association of GSTM1, CYP1A1 and CYP2E1 genetic polymorphisms with susceptibility to lung adenocarcinoma: a case-control study in Chinese population.
Wang J; Deng Y; Li L; Kuriki K; Ding J; Pan X; Zhuge X; Jiang J; Luo C; Lin P; Tokudome S
Cancer Sci; 2003 May; 94(5):448-52. PubMed ID: 12824892
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms in the cytochromes P-450 (1A1, 2E1), microsomal epoxide hydrolase and glutathione S-transferase M1, T1, and P1 genes, and their relationship with chronic bronchitis and relapsing pneumonia in children.
Korytina GF; Yanbaeva DG; Babenkova LI; Etkina EI; Victorova TV
J Mol Med (Berl); 2005 Sep; 83(9):700-10. PubMed ID: 15928955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
